Rössle M. TIPS: 25 years later. J Hepatol. 2013;59:1081–1093. https://doi.org/10.1016/j.jhep.2013.06.014.

Article  Google Scholar 

de Franchis R, Baveno VIF. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743–752. https://doi.org/10.1016/j.jhep.2015.05.022.

Article  Google Scholar 

Bettinger D, Schultheiss M, Boettler T, Muljono M, Thimme R, Rössle M. Procedural and shunt-related complications and mortality of the transjugular intrahepatic portosystemic shunt (TIPSS). Aliment Pharmacol Ther. 2016;44:1051–1061. https://doi.org/10.1111/apt.13809.

Article  CAS  Google Scholar 

Sarwar A, Zhou L, Novack V, Tapper EB, Curry M, Malik R et al. Hospital volume and mortality after transjugular intrahepatic portosystemic shunt creation in the United States. Hepatology 2018;67:690–699. https://doi.org/10.1002/hep.29354.

Article  Google Scholar 

Ronald J, Wang Q, Choi SS, Suhocki PV, Hall MD, Smith TP et al. Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation. Diagn Interv Imaging 2018;99:163–168. https://doi.org/10.1016/j.diii.2017.10.008.

Article  CAS  Google Scholar 

Sturm L, Praktiknjo M, Bettinger D, Huber JP, Volkwein L, Schmidt A et al. Prognostic value of the CLIF-C AD score in patients with implantation of transjugular intrahepatic portosystemic shunt. Hepatol Commun 2021;5:650–660. https://doi.org/10.1002/hep4.1654.

Article  CAS  Google Scholar 

Young S, Rostambeigi N, Golzarian J, Lim N. MELD or sodium MELD: a comparison of the ability of two scoring systems to predict outcomes after transjugular intrahepatic portosystemic shunt placement. AJR Am J Roentgenol. 2020;215:215–222. https://doi.org/10.2214/AJR.19.21726.

Article  Google Scholar 

Kim WR, Mannalithara A, Heimbach JK, Kamath PS, Asrani SK, Biggins SW et al. MELD 30: the model for end-stage liver disease updated for the modern era. Gastroenterology. 2021. https://doi.org/10.1053/j.gastro.2021.08.050.

Article  Google Scholar 

Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91–96. https://doi.org/10.1053/gast.2003.50016.

Article  Google Scholar 

Bettinger D, Sturm L, Pfaff L, Hahn F, Kloeckner R, Volkwein L et al. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival. J Hepatol. 2021;74:1362–1372. https://doi.org/10.1016/j.jhep.2021.01.023.

Article  CAS  Google Scholar 

Song J, Wang X, Yan Y, Xiang T, Luo X. Validating the prognostic value of Freiburg index of posttransjugular intrahepatic portosystemic shunt survival score and classic scores in Chinese patients with implantation of transjugular intrahepatic portosystemic shunt. Eur J Gastroenterol Hepatol. 2022;34:1074–1080. https://doi.org/10.1097/meg.0000000000002427.

Article  CAS  Google Scholar 

Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864–871. https://doi.org/10.1053/he.2000.5852.

Article  CAS  Google Scholar 

Leise MD, Kim WR, Kremers WK, Larson JJ, Benson JT, Therneau TM. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation. Gastroenterology 2011;140:1952–1960. https://doi.org/10.1053/j.gastro.2011.02.017.

Article  Google Scholar 

Galle PR, Forner A, Llovet JM, Mazzaferro V, Piscaglia F, Raoul J-L et al. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236. https://doi.org/10.1016/j.jhep.2018.03.019.

Article  Google Scholar 

D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217–231. https://doi.org/10.1016/j.jhep.2005.10.013.

Article  Google Scholar 

Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464–470. https://doi.org/10.1053/jhep.2001.22172.

Article  CAS  Google Scholar 

Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006;130:1652–1660. https://doi.org/10.1053/j.gastro.2006.02.010.

Article  Google Scholar 

Locke JE, Shelton BA, Olthoff KM, Pomfret EA, Forde KA, Sawinski D et al. Quantifying sex-based disparities in liver allocation. JAMA Surg 2020;155:201129. https://doi.org/10.1001/jamasurg.2020.1129.

Article  Google Scholar 

Allen AM, Heimbach JK, Larson JJ, Mara KC, Kim WR, Kamath PS et al. Reduced access to liver transplantation in women: role of height, MELD exception scores, and renal function underestimation. Transplantation 2018;102:1710–1716. https://doi.org/10.1097/tp.0000000000002196.

Article  Google Scholar 

Alessandria C, Gaia S, Marzano A, Venon WD, Fadda M, Rizzetto M. Application of the model for end-stage liver disease score for transjugular intrahepatic portosystemic shunt in cirrhotic patients with refractory ascites and renal impairment. Eur J Gastroenterol Hepatol. 2004;16:607–612. https://doi.org/10.1097/00042737-200406000-00015.

Article  Google Scholar 

Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlich J et al. Child-pugh versus mELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003;52:879–885. https://doi.org/10.1136/gut.52.6.879.

Article  CAS  Google Scholar 

Wang Q, Bai W, Han G. Freiburg index of post-TIPS survival: the first score for individual prediction and a complementary tool for risk stratification. J Hepatol. 2021. https://doi.org/10.1016/j.jhep.2021.05.042.

Article  Google Scholar 

Kraglund F, Gantzel RH, Jepsen P, Aagaard NK. External validation of the Freiburg index of post-TIPS survival. J Hepatol. 2021. https://doi.org/10.1016/j.jhep.2021.04.027.

Article  Google Scholar 

Tripodi A, Chantarangkul V, Primignani M, Fabris F, Dell’Era A, Sei C et al. The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation. Hepatology 2007;46:520–527. https://doi.org/10.1002/hep.21732.

Article  Google Scholar 

Luca A, Miraglia R, Maruzzelli L, D’Amico M, Tuzzolino F. Early liver failure after transjugular intrahepatic portosystemic shunt in patients with cirrhosis with model for end-stage liver disease score of 12 or less: incidence, outcome, and prognostic factors. Radiology 2016;280:622–629. https://doi.org/10.1148/radiol.2016151625.

Article  Google Scholar